ArticleBrain and behavior2020

Adjunct ketamine treatment of depression in treatment-resistant schizophrenia patients is unsatisfactory in pilot and secondary follow-up studies.

Chuanjun Zhuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.